Navigation Links
Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis

ion to treat pain, nausea, vomiting, and even malnutrition. Gastroparesis represents a significant unmet medical need as Propulsid(TM) (cisapride), the most widely used product for treating this disorder was removed from the U.S. market in 2000 due to significant cardiovascular adverse effects.

Tranzyme earlier reported that TZP-101 demonstrated excellent tolerability and safety, as well as a desirable pharmacokinetic profile in healthy subjects in two Phase I clinical studies. The Company plans to initiate full Phase II development of TZP-101 for both POI and severe gastroparesis in 3Q 2007. In addition to the ongoing clinical testing of TZP-101 (an intravenous drug), Tranzyme is developing a new oral ghrelin agonist, TZP-102. Tranzyme expects to initiate Phase I clinical testing of TZP-102 in the first quarter of 2008 for the treatment of mild to moderate chronic gastroparesis.

"The Company is making great progress in the development of TZP-101," said Dr. Vipin Garg, President & CEO of Tranzyme Pharma. "Tranzyme's novel ghrelin agonists (TZP-101 and TZP-102) are promising breakthrough drugs with huge commercial potential. Most prokinetic agents under development and on the market act on predominantly central nervous system receptor targets that are also found in the GI tract. Many show potentially serious CNS side effects. Our small molecule ghrelin agonists target a receptor that is more directly involved with regulating gastrointestinal motility."

About Gastroparesis

Gastroparesis results from dysfunction of the nerves of the stomach, leading to postprandial fullness, bloating, early satiety, nausea and vomiting. The three most common etiologies of gastroparesis are diabetes (an estimated 30% of gastroparesis patients), unknown etiology (36%), and post-surgical causes (13%). The prevalence rate of gastroparesis is especially high among diabetic patients, as up to 50% of diabetics worldwide are reported to suffer from gastroparesis
'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:8/26/2014)... (NYSE: ACT ), a leading global specialty pharmaceutical ... President of Actavis, will provide an overview and update of ... 2014 in New York, NY . ... will take place on Tuesday, September 9, 2014 at 11:10 ... East 42 nd Street, New York, NY ...
(Date:8/26/2014)... , Aug. 26, 2014 Blue Bell, ... largest office worldwide. PRA, a leading global Contract Research Organization (CRO), ... Fort Washington locations into new modern Class ... new office opened this week and marks the first phase of ... for us at PRA," said Harris Koffer , President of ...
(Date:8/26/2014)... 2014   Quanta Aesthetic Lasers , the premier emerging ... , expands the offerings in their robust product portfolio with ... available for shipping to medical spas, clinics, and doctors, offices ... The QuantaShape is manufactured in the Chianti hills of ... The device was previously sold as both the VASERShape™ and ...
Breaking Medicine Technology:Actavis to Present at Morgan Stanley Global Healthcare Conference 2014 2PRA Health Sciences Expands in Pennsylvania 2Another Italian Beauty Joins the Quanta Aesthetic Lasers Lineup 2
... 2011 Milestone Scientific Inc. (Pink Sheets: ... injection systems for medical and dental markets, today announced ... OTCQB(TM) electronic quotation and trading system under the ticker ... action as a result of the addition of the ...
... Texas, March 14, 2011 (Nasdaq: VRML ... inclusion of OVA1® as part of the recently published ... Obstetrics and Gynecology , the American College of Obstetricians ... published an update committee opinion on the role of ...
Cached Medicine Technology:Milestone Scientific Inc. Commences Trading on the OTC Pink 2OVA1 Included in Latest ACOG/SGO Committee Opinion 2OVA1 Included in Latest ACOG/SGO Committee Opinion 3OVA1 Included in Latest ACOG/SGO Committee Opinion 4
(Date:8/27/2014)... Ellen V. Krieger, DDS released a new video describing her ... to describe the business and industry best practices for ... of cosmetic and family dentistry experience, Dr Ellen Krieger is ... and cared for. , Dr. Krieger has practiced dentistry in ... solid reputation of offering bright, friendly service to all of ...
(Date:8/27/2014)... August 27, 2014 Top10BestSEOHosting.com compares ... and GoDaddy are the most recommended suppliers for ... products. , “GreenGeeks and GoDaddy provide stellar ... believe that they have managed to provide a ... an intuitive ease of use that helps diminish ...
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 DiabetesSisters ... event in collaboration with Diabetes Community Advocacy Foundation (DCAF) ... October 24-25, 2014 at Embassy Suites LAX North. The ... Media Meetup featuring DSMA Live”, an event which is ... evening, October 24th. , Interactive in many ways, DiabetesSisters’ ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The world ... transformation as was revealed in a survey conducted recently ... not just surprising but astonishing as well, and for ... online interviewed existing members on the 10yeargap website and ... to Kaly, 10yeargap marketing department manager," there are more ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... governance, and compliance software solutions for next-generation social ... Inc. magazine’s Inc. 500|5000, an exclusive ranking of ... consecutive year. AvePoint joins brands such as Alex ... 2014 edition. , This underscores continued growth ...
Breaking Medicine News(10 mins):Health News:Ellen V. Krieger, DDS of McLean, Virginia Announces New Video Describing Industry Best Practices 2Health News:Excellent Hosting Suppliers Recommended By Top10BestSEOHosting.com 2Health News:DiabetesSisters and Diabetes Community Advocacy Foundation Join Forces to Bring Together People with Diabetes in Los Angeles 2Health News:DiabetesSisters and Diabetes Community Advocacy Foundation Join Forces to Bring Together People with Diabetes in Los Angeles 3Health News:Survey Reveals Younger Women Dating Older Men 2Health News:Survey Reveals Younger Women Dating Older Men 3Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3
... discovered previously unsuspected mutations that contribute to the formation ... common cancer in children. The discovery not only suggests ... a roadmap for the identification of unsuspected mutations in ... in which immature white blood cells that normally develop ...
... grim facts to state. The study estimates that more than ... and that it also takes more than two years to ... 125,000 Australians suffer from some sort of autism indicted by ... this means that autism affects half a million Australians. ...
... findings by Dutch researchers suggest that the hormone glucocorticoids ... to be//. The steroid is prescribed by many specialists ... ,The steroid hormones called glucocorticoids are employed by ... to influence the body’s immune responses in a good ...
... A medical college counsellor set afire by his patient ... Chandra Bose Medical College hospital// in Jabalpur where the ... counsellor, Sanjay Shrivastava suffered 80 percent burns when he ... Sidhi district. The counsellor had refused to advise Jaiswal ...
... and beans aren't the only foods that pack a ... start to pregnancy. ,Researchers now have used ... full day's worth of the nutrient in a single ... online edition of the journal PNAS, Proceedings of the ...
... UC Irvine researchers have combined genetic and geographic data ... history over the past decade. //They found that multiple ... of Guangdong, and they identified many of the migration ... ,By knowing where H5N1 strains develop and ...
Cached Medicine News:Health News:Major Gene Study Uncovers Secrets of Leukemia 2Health News:Major Gene Study Uncovers Secrets of Leukemia 3Health News:Scientists Genetically Engineer Tomatoes With Enhanced Folate Content 2Health News:UCI Scientists Reconstruct Migration of Avian Flu Virus 2
...
1.7% Tryptone, 0.3% Soytone, 0.5% Sodium Chloride, 0.25% Dextrose, 0.25% Potassium Phosphate....
... The basic Thermomixer is a compact model ... 24 x 1.5 ml tubes. Impressive features ... clear design, and high stabilityeven at maximum ... for gentle to vigorous mixing, including intermittent ...
... Penicillin/25,000 ug Streptomycin All ... and Buffer products are ... cGMP regulations and are ... assure compatibility. , Typical ...
Medicine Products: